Page URL: https://www.bionews.org.uk/page_89975

EU still cannot reach agreement on ES cell funding

16 March 2006
By BioNews
Appeared in BioNews 350

Following discussions earlier this week, European Union (EU) research ministers have failed to find a majority opinion on how human embryonic stem cell (ES cell) research should be funded under the Seventh EU Research Framework Programme 2007-2013 (FP7). Because of the lack of agreement among member states, the EU will continue to take a 'passive' approach to funding. The EU is also being pressed to make a decision on a pan-European cloning policy alongside the funding issue. Many governments across Europe are under pressure to allow the creation of in vitro embryo for research, including cloning - and some countries, like the UK, already allow this. However, Poland and Italy are standing firm against making this an EU-wide policy.

Some EU member states ban ES cell research in its entirety, while others favour a more liberal regulatory approach, allowing such research to take place, but under strict guidelines. Such disparity of treatment across Europe makes it seem unlikely that any central consensus about funding is achievable. Because of this, a policy on ES cell research that applies to the whole of the EU has proved impossible, particularly as Roman Catholic countries such as Italy or Poland, who traditionally are against embryo research, could block any votes. In addition, Austria, which currently holds the rotating EU presidency, is among countries that ban the use of ES cells for research. In 2004, Italy passed very restrictive legislation on IVF and related technologies, including embryo research. Other predominantly Catholic European countries ban or restrict the use of human embryos.

Because of the lack of agreement on how to regulate or fund ES cell research in Europe, the EU currently has no general policy on ES cell research funding; rather, applications for research funding are considered on a case-by-case basis by a committee under the current framework programme (FP6), which ends this year. In order to qualify for research funds, projects must show a need to use ES cells, by establishing that the same research cannot be undertaken using adult stem cells, such as those derived from bone marrow. Only six projects using ES cells have been approved for EU funds so far.

Following the meeting earlier this week, a European Commission official said 15 of the 25 member states favored continuing the case-by-case approach. Elisabeth Gehrer, Austria's minister for education, science and culture, said that in the light of the disagreements about ES cells, the simplest solution would be to carry on with the system as it currently stands. 'We still think that adult stem cell research is preferable to embryonic stem cells, but we don't have a qualified majority in favour of this', she said.

SOURCES & REFERENCES
EU fails to agree on common embryo research policy
Reuters |  13 March 2006
European Union Can't Agree on Embryonic Stem Cell Research Policy
LifeNews.com |  14 March 2006
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
11 December 2006 - by Dr Jess Buxton 
The European Parliament's approval of funding for some human embryonic stem cell research reflects inequality in how individual countries recognise fundamental rights, according to a Vatican official. Following 19 months of negotiations and 2000 amendments - 700 of which were put to a vote - the 7th Framework...
31 July 2006 - by Dr Jess Buxton 
UK physicist Stephen Hawking, who has motor neuron disease, has described the recent decision on European Union (EU) funding for human embryonic stem (ES) cell research as a 'fudge'. Last week, European Ministers agreed the latest draft of Europe's 54.5 billion Euro (£38 billion) 2007-2013...
24 July 2006 - by Dr Jess Buxton 
European Ministers have agreed to fund some human embryonic stem (ES) cell research, in a compromise that bans any work involving the destruction of embryos. However, this would not prevent European funding of 'subsequent steps', the Ministers agreed at a European Council meeting held today. UK...
19 June 2006 - by Dr Jess Buxton 
The European parliament has voted to allow European Union (EU) funding for projects involving human embryonic stem (ES) cell research. In the latest stage of the approval for Europe's 2007-2013 research budget, the 7th Framework Programme (FP7), politicians backed the proposal by 284 votes to...
17 October 2005 - by BioNews 
A group of 73 members of the European Parliament (MEPs) has sent a letter to the commission president Manuel Barroso, calling for an end to EU funding of research using human embryonic stem (ES) cells. The call followed the commission's unveiling of its draft priorities for the next round of...
25 April 2005 - by BioNews 
The European Commissioner for Science and Research has said that he will not directly increase European Union (EU) funding for human embryonic stem (ES) cell research, even though the money allocated for scientific research as a whole has greatly increased. The proposed Seventh EU Research Framework Programme 2007-2013 (FP7...
7 March 2005 - by BioNews 
European scientists who want to work on human embryonic stem (ES) cells may feel inhibited by laws in their own countries that ban such research, even if they are working elsewhere. The problems arising from the diverse range of regulations governing stem cell research in Europe were raised in a...
3 December 2003 - by BioNews 
The ongoing debate on whether European Union (EU) funds will be able to be used for human embryonic stem (ES) cell research has failed to be reconciled today. The Council of Ministers has failed to agree on funding in a final attempt to resolve the issue before a moratorium on...
10 November 2003 - by BioNews 
Two votes that will affect funding and support for embryo stem cell research took place in the European Parliament last week. The Environment Committee voted against proposals that sought to ban embryo stem cell research in the European Union (EU) member states, while the Industry Committee voted in favour of...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.